General MedicationsOPHTHALMICStandard
TRAVOPROST
TRAVOPROST
Standard Dose
0.004%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview TRAVOPROST is listed in Drugs@FDA under application 218159 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient TRAVOPROST Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.004% Sponsor GLAND Submission history Latest submission status date: 2024-07-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview TRAVOPROST is listed in Drugs@FDA under application 218159 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TRAVOPROST Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.004% Sponsor GLAND Submission history Latest submission status date: 2024-07-12 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.